Skip to main content

Home
OUR XCHANGES
INDUSTRY EXPERTS
NEWS XCHANGE
PARTNERSHIPS
ABOUT US

Home
OUR XCHANGES
INDUSTRY EXPERTS
NEWS XCHANGE
PARTNERSHIPS
ABOUT US

Home
OUR XCHANGES
INDUSTRY EXPERTS
NEWS XCHANGE
PARTNERSHIPS
ABOUT US

Oligonucleotide Therapeutics Xchange - Boston - 2024

Loading

Novel new modalities for oligonucleotides.

21 Jun 2024

15:50 - 16:50

Salon A

New Modalities

Industry Expert

Dan Roseman, Associate Director, Analytical CMC Strategy - Bristol-Myers Squibb

hubXchange

27 Old Gloucester Street

London
WC1N 3AX

+44 20 3371 9932
info@hub-xchange.com

About

hubXchange specialises in delivering high-level content, intelligence and connections to the global life sciences community by hosting outstanding business Xchanges.

Links

About Company
Our Xchanges
Industry Experts
Partnerships
Terms & Conditions
Contact Us

Hubxchange logo

Company Details

© 2017 HUB XCHANGE LIMITED. All Rights Reserved. Registered Office: 27 Old Gloucester Street, London, England, WC1N 3AX VAT Registration No. 281308022 - Registered in England No. 10714971

© Copyright 2024

Exhibition Website by ASP

LinkedIn
YouTube
Search

Search

Username *

Password *